The main points of the TPD in relation to e-cigarettes are as follows:

• E-cigarettes may be sold as licensed medical products, in which case they are not subject to the limitations imposed by the TPD.
• E-cigarettes and e-liquid not sold as medical products are considered to be tobacco products, and may be sold subject to TPD regulation.
• All products must be notified to the competent authority (DH) 6 months prior to being placed on the market. Products already on the market on 20^th May 2016 must be notified within 6 months of that date. The notification procedure is complex and requires substantial testing and technical work for every product.
• E-liquid may only be sold in pre-filled cartridges containing 2ml or less, or dedicated refill containers containing 10ml or less.
• E-liquid may not exceed nicotine content of 20mg/ml.
• Only high purity ingredients that do not pose a risk to human health may be used in e-liquid.
• Consistent nicotine doses must be delivered in consistent operating conditions.
• E-cigarettes and refill containers must be child and tamper proof, protected against breakage and leakage, and when refillable there must be a mechanism that ensures leak free refilling.
• Information leaflets must be included with all e-cigarette and e-liquid products.
• Ingredients should be listed in descending order of weight, with a notification of nicotine delivery per dose.
• Promotion and advertising of e-cigarettes by print, radio, televisual or public event media is prohibited.
• Submission of comprehensive sales and marketing data is required